LABCORP ENDPOINT CLINICAL INC.
DURHAM, NC

LABCORP ENDPOINT CLINICAL INC., previously known as ENDPOINT CLINICAL, INC., is a Delaware-registered company headquartered in Durham, Leon County, Florida. Incorporated on February 5, 2015, the company specializes in clinical endpoint management and has established itself as a leader in providing electronic data reconciliation and integrated randomization technology (IRT) for clinical trials. With its flagship software platform PULSE, LABCORP ENDPOINT CLINICAL INC. revolutionizes IRT by enhancing speed, flexibility, and control over clinical trial and supply chain management. PULSE offers rapid development of a customized IRT system that facilitates the monitoring of study data and administration via mobile platforms, delivering efficiency at considerably lower costs than competitors. The company extends its offerings with DRIVE, automating supply management across all phases of clinical trials to minimize costs, reduce waste, and ensure regulatory compliance. These tools are complemented by NUDGE’s message center, enhancing communication for efficient trial operations through study confirmation messages delivered directly via portal sites. Moreover, the organization ensures adherence to FDA regulations such as 21 CFR Part 11 and GxPs, alongside EU legislation, with its comprehensive quality management system (QMS). Its dedicated quality assurance team regularly reviews processes and supports vendor audits to maintain compliance and oversight efficacy. Under the leadership of Amedeo De Risi (Director), David Cooper (President), and Jill McConnell (Director), LABCORP ENDPOINT CLINICAL INC. continues its commitment to improving clinical trial management, backed by a robust quality philosophy focused on continuous enhancement. The company's address is 55 Francisco Street, San Francisco, CA, 94133, US, with contact numbers as (415) 229-1600; (877) 810-4786; (415) 970-5546. Additional details can be found on their website: endpointclinical.com.